Borderline Exocrine Pancreatic Neoplasm

Borderline Exocrine Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06157671	The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma	enrolling by invitation	—	1,000	Adenocyte, LLCINDUSTRY	1	Aug 6, 2026	clinicaltrials
NCT07709052	Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)(B-PDAC)	not yet recruiting	—	180	Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisOTHER	0	Jul 16, 2026	clinicaltrials
NCT07117045	Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer(AI-LDCT-PC)	recruiting	—	400,000	Changhai HospitalOTHER	1	Aug 12, 2025	clinicaltrials
NCT06276803	The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Data updated 22 days agoSource updated Aug 6, 2026source: clinicaltrials